| Clinical data | |
|---|---|
| Other names | WIN-1783, BW 47-442 |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG |
|
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C21H27NO |
| Molar mass | 309.453 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Isomethadone (INN,BAN; trade nameLiden; also known asisoamidone) is asyntheticopioidanalgesic andantitussive related tomethadone that was used formerly as apharmaceuticaldrug but is now no longer marketed.[2][3][4][5] Isomethadone was used as both ananalgesic andantitussive. It binds to and activates both theμ- andδ-opioid receptors, with the (S)-isomer being the morepotent of the twoenantiomers.[6] Isomethadone is aSchedule IIcontrolled substance in theUnited States, with an ACSCN of 9226 and a 2014 aggregate manufacturing quota of 5 g. Thesalts in use are the hydrobromide (HBr, free base conversion ratio 0.793), hydrochloride (HCl, 0.894), and HCl monohydrate (0.850).[7] Isomethadone is also regulated internationally as aSchedule I controlled substance under theUnited NationsSingle Convention on Narcotic Drugs of 1961.[8]